Harvard Bioscience (HBIO) Competitors $0.47 -0.02 (-3.37%) As of 03:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HBIO vs. TMO, A, MTD, WAT, ILMN, TECH, CRL, BIO, BRKR, and PACBShould you be buying Harvard Bioscience stock or one of its competitors? The main competitors of Harvard Bioscience include Thermo Fisher Scientific (TMO), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), and Pacific Biosciences of California (PACB). These companies are all part of the "life sciences tools & services" industry. Harvard Bioscience vs. Its Competitors Thermo Fisher Scientific Agilent Technologies Mettler-Toledo International Waters Illumina Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience (NASDAQ:HBIO) and Thermo Fisher Scientific (NYSE:TMO) are both life sciences tools & services companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment. Do insiders and institutionals hold more shares of HBIO or TMO? 80.9% of Harvard Bioscience shares are owned by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 9.5% of Harvard Bioscience shares are owned by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Do analysts rate HBIO or TMO? Harvard Bioscience presently has a consensus target price of $2.00, suggesting a potential upside of 328.27%. Thermo Fisher Scientific has a consensus target price of $592.24, suggesting a potential upside of 22.62%. Given Harvard Bioscience's higher probable upside, research analysts plainly believe Harvard Bioscience is more favorable than Thermo Fisher Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Harvard Bioscience 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Thermo Fisher Scientific 0 Sell rating(s) 5 Hold rating(s) 17 Buy rating(s) 0 Strong Buy rating(s) 2.77 Does the media refer more to HBIO or TMO? In the previous week, Thermo Fisher Scientific had 68 more articles in the media than Harvard Bioscience. MarketBeat recorded 71 mentions for Thermo Fisher Scientific and 3 mentions for Harvard Bioscience. Thermo Fisher Scientific's average media sentiment score of 1.47 beat Harvard Bioscience's score of 1.04 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Harvard Bioscience 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Thermo Fisher Scientific 61 Very Positive mention(s) 5 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, HBIO or TMO? Harvard Bioscience has a beta of 1.54, indicating that its share price is 54% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. Is HBIO or TMO more profitable? Thermo Fisher Scientific has a net margin of 15.24% compared to Harvard Bioscience's net margin of -64.68%. Thermo Fisher Scientific's return on equity of 16.82% beat Harvard Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Harvard Bioscience-64.68% -5.64% -2.15% Thermo Fisher Scientific 15.24%16.82%8.38% Which has better earnings & valuation, HBIO or TMO? Thermo Fisher Scientific has higher revenue and earnings than Harvard Bioscience. Harvard Bioscience is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHarvard Bioscience$94.14M0.22-$12.40M-$1.30-0.36Thermo Fisher Scientific$42.88B4.25$6.34B$17.2927.93 SummaryThermo Fisher Scientific beats Harvard Bioscience on 13 of the 16 factors compared between the two stocks. Get Harvard Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for HBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HBIO vs. The Competition Export to ExcelMetricHarvard BioscienceINSTRU IndustryComputer SectorNASDAQ ExchangeMarket Cap$20.75M$878.90M$32.07B$10.40BDividend YieldN/A0.62%3.16%4.63%P/E Ratio-0.3625.05450.2626.72Price / Sales0.221.101,985.62161.45Price / Cash4.6219.3837.2060.63Price / Book0.322.327.596.38Net Income-$12.40M$17.67M$809.77M$271.62M7 Day Performance5.75%6.60%4.13%2.73%1 Month Performance-4.11%-7.30%9.14%9.49%1 Year Performance-83.20%-25.82%24,222.69%31.36% Harvard Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HBIOHarvard Bioscience4.1119 of 5 stars$0.47-3.4%$2.00+328.3%-82.6%$20.75M$94.14M-0.36490Positive NewsShort Interest ↑Gap DownTMOThermo Fisher Scientific4.9686 of 5 stars$487.11-1.1%$589.38+21.0%-21.2%$186.01B$42.88B28.17125,000Positive NewsAAgilent Technologies4.6722 of 5 stars$128.13-0.5%$139.25+8.7%-8.2%$36.50B$6.51B30.0817,900Dividend AnnouncementMTDMettler-Toledo International4.1634 of 5 stars$1,314.38+0.7%$1,311.11-0.2%-8.1%$26.90B$3.87B33.2817,300Positive NewsWATWaters4.764 of 5 stars$309.58+1.1%$378.73+22.3%-7.9%$18.23B$3.05B27.927,600ILMNIllumina4.7333 of 5 stars$98.18-0.8%$123.06+25.3%-21.3%$15.21B$4.37B12.439,030Positive NewsTECHBio-Techne4.9849 of 5 stars$54.11-0.6%$70.42+30.1%-30.7%$8.53B$1.22B117.633,100Positive NewsCRLCharles River Laboratories International4.6597 of 5 stars$161.97-1.2%$175.69+8.5%-23.7%$8.07B$4.05B-121.7820,100Positive NewsAnalyst RevisionBIOBio-Rad Laboratories4.6835 of 5 stars$290.32-1.7%$333.50+14.9%-16.1%$8.00B$2.57B24.757,700Positive NewsBRKRBruker4.9785 of 5 stars$30.80-0.1%$51.30+66.6%-50.2%$4.68B$3.37B59.2311,396Short Interest ↑PACBPacific Biosciences of California1.9991 of 5 stars$1.25-1.6%$1.90+52.0%-33.7%$381.47M$154.01M-0.55730 Related Companies and Tools Related Companies TMO Competitors A Competitors MTD Competitors WAT Competitors ILMN Competitors TECH Competitors CRL Competitors BIO Competitors BRKR Competitors PACB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HBIO) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harvard Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harvard Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.